Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.

View source ↗

Summary

The update describes ongoing surveillance for potential early liver injuries linked to Yangxue Shengfa Capsule, highlighting hepatotoxicity safety monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Drugs mentioned

• Yangxue Shengfa Capsule

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Drug-Induced Liver Injury | Status: UNKNOWN